Effects of neoadjuvant chemotherapy on immune microenvironment and clinical outcomes in locally advanced gastric cancer.

被引：0
|
作者：
Yu, Yue
Zeng, Yi-Xin
Zhou, Ai-Ping
Ma, Xiaopeng
Zhang, Yun
Shen, Zhirong
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e24133
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e24133
引用
收藏
页数：2
相关论文
共 50 条
  • [31] FACTORS PREDICTING RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED GASTRIC CANCER
    Yildirim, Emine
    Bektas, Sibel
    Goktas Aydin, Sabin
    Muzaffer, Ahmet E. R.
    Yanik, Irem
    Gumuskaya, Perihan Ozkan
    Yilmaz, Barbaros Utku
    Bilici, Ahmet
    Oncel, Mustafa
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2022,
  • [32] Safety and efficacy of neoadjuvant chemotherapy with S-1 and oxaliplatin plus apatinib for locally advanced gastric cancer.
    Zheng, Ya'nan
    Yang, Xiao
    Ni, Zhentian
    Zhu, Zhenglun
    Xu, Wei
    Yang, Zhongyin
    Liu, Wentao
    Yan, Min
    Zhu, Zhenggang
    Li, Chen
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Phase I study of neoadjuvant chemotherapy with xeloda and oxaliplatin (G-XELOX) for locally advanced gastric cancer.
    Satake, Hironaga
    Kondo, Masato
    Kotake, Takeshi
    Okita, Yoshihiro
    Ogata, Takatsugu
    Hatachi, Yukimasa
    Yasui, Hisateru
    Kaihara, Satoshi
    Kotaka, Masahito
    Kato, Takeshi
    Tsuji, Akihito
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [34] Survival outcomes of locally advanced gastric cancer cases with pathological complete response received neoadjuvant chemotherapy
    Hu, Qing
    Wang, Jian
    Xu, Wei-Guo
    Shao, Peng
    Li, Gang
    PRECISION MEDICAL SCIENCES, 2021, 10 (02): : 78 - 82
  • [35] DOWNSTAGING EFFECTS OF NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED COLON CANCER
    Verstegen, M.
    Gooyer, J.
    't Lam-Boer, J.
    Radema, S.
    Elfrink, M.
    Verhoef, C.
    Schreinemakers, J.
    de Wilt, J.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E82 - E83
  • [36] Phase II study of paclitaxel and capecitabine (PX) combination as neoadjuvant chemotherapy for unresectable locally advanced gastric cancer.
    Ko, Yoon Ho
    Hong, Sook Hee
    Roh, Sang Young
    Song, Kyo Young
    Jung, Eun Sun
    Jeon, Hae Myung
    Park, Cho Hyun
    Hong, Young Seon
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] A phase II study of neoadjuvant chemotherapy with a modified FOLFOX6 regimen for locally advanced gastric cancer.
    Wang, Xiang
    Zhao, Lin
    Liu, Hongfeng
    Bai, Chunmei
    Li, Xiaoyi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [38] Morphologic effects of neoadjuvant chemotherapy in locally advanced breast cancer
    Moll, UM
    Chumas, J
    PATHOLOGY RESEARCH AND PRACTICE, 1997, 193 (03) : 187 - 196
  • [39] Clinical outcomes of locally advanced cervical cancer with neoadjuvant chemotherapy: Single institute experience data
    Kwack, J. Y.
    Kwon, Y. S.
    Lee, S. H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 381 - 384
  • [40] PRELIMINARY ASSESSMENT OF SAFETY AND EFFICACY OF NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED COLON CANCER.
    Arredondo, J.
    Fernandez, J.
    Villafane, A.
    Castanon, C.
    Alvarez, M.
    Rodriguez, C.
    Tejedor, P.
    Pastor, C.
    DISEASES OF THE COLON & RECTUM, 2021, 64 (05)
12345